Figure 5

Differences in tobramycin response and aggregation between persistent and eradicated P. aeruginosa isolates in glass slide chamber. Eradicated (nā=ā7) and persistent (nā=ā4) P. aeruginosa isolates grown for 24Ā h as biofilms in glass slide chamber and then treated with 1000 µg/mL tobramycin for an additional 24Ā h then visualized with confocal microscopy. LB: Lysogeny Broth alone;ā+āT: plus Tobramycin; SS: in presence of 5% pooled CF Sputum Supernatant. Horizontal line, median. (A) average P. aeruginosa biovolume intensity (µm3)/well, (B) average luminescence in relative light units (RLU) of ATP assay/well, (C) average degree of aggregation measured by surface to biovolume ratio/well. *pā<ā0.05, **pā<ā0.01, ***pā<ā0.001, ns: not significant using MannāWhitney test.